The hydrophilic interaction UPLC-MS/MS method was used for the quantification of saracatinib in HLMs. Small changes to the N -methyl piperazine in drug design might improve the metabolic stability of new derivatives compared with that of saracatinib.
Attwa et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: